WST * logo

West Pharmaceutical Services BMV:WST * Stock Report

Last Price

Mex$4.50k

Market Cap

Mex$315.6b

7D

-36.3%

1Y

n/a

Updated

16 Feb, 2025

Data

Company Financials +

West Pharmaceutical Services, Inc.

BMV:WST * Stock Report

Market Cap: Mex$315.6b

WST * Stock Overview

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details

WST * fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Price-To-Earnings ratio (31.6x) is below the Life Sciences industry average (35x)

Analysts in good agreement that stock price will rise by 42.4%

Risk Analysis

Shares are highly illiquid


My Notes

Capture your thoughts, links and company narrative

West Pharmaceutical Services, Inc. Competitors

Divi's Laboratories

NSEI:DIVISLAB

₹1.6t

Avantor

NYSE:AVTR

US$12.2b

Revvity

NYSE:RVTY

US$13.7b

ICON

NasdaqGS:ICLR

US$15.4b

Price History & Performance

Summary of share price highs, lows and changes for West Pharmaceutical Services
Historical stock prices
Current Share PriceUS$4,500.00
52 Week HighUS$7,104.95
52 Week LowUS$4,271.86
Beta1
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Change-43.48%
5 Year Changen/a
Change since IPO-45.63%

Recent News & Updates

Recent updates

Shareholder Returns

WST *MX Life SciencesMX Market
7D-36.3%0%0%
1Yn/a0%0%

Return vs Industry: Insufficient data to determine how WST * performed against the MX Life Sciences industry.

Return vs Market: Insufficient data to determine how WST * performed against the MX Market.

Price Volatility

Is WST *'s price volatile compared to industry and market?
WST * volatility
WST * Average Weekly Movementn/a
Life Sciences Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in MX Market0%
10% least volatile stocks in MX Market0%

Stable Share Price: WST *'s share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine WST *'s volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
192310,600Eric Greenwww.westpharma.com

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.

West Pharmaceutical Services, Inc. Fundamentals Summary

How do West Pharmaceutical Services's earnings and revenue compare to its market cap?
WST * fundamental statistics
Market capMex$315.60b
Earnings (TTM)Mex$10.00b
Revenue (TTM)Mex$58.72b

31.6x

P/E Ratio

5.4x

P/S Ratio

Is WST * overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WST * income statement (TTM)
RevenueUS$2.89b
Cost of RevenueUS$1.89b
Gross ProfitUS$998.50m
Other ExpensesUS$505.80m
EarningsUS$492.70m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)6.80
Gross Margin34.51%
Net Profit Margin17.03%
Debt/Equity Ratio11.2%

How did WST * perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

12%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 12:08
End of Day Share Price 2025/02/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

West Pharmaceutical Services, Inc. is covered by 23 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Lawrence MarshBarclays
Michael RyskinBofA Global Research